纤维细胞生长因子23与血液透析患者末期脏疾病的生物化学参数之间的相关性
Barat Yusubov1, Mirkhalig Javadov2, Khanbaba Huseynov3
1Department of Nephrology, Yeni Klinika Hospital, Baku, AZE.
Cureus
|July 4, 2025
概括
纤维细胞生长因子23 (FGF-23),完整的副甲状腺激素 (iPTH) 和同类素 (Hcy) 与血液透析患者的关键标志物相关. 监测这些生物标志物可能有助于早期发现和治疗慢性病的策略.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 生物化学 生物化学
- 内部医学 内部医学
背景情况:
- 纤维细胞生长因子23 (FGF-23) 是血液透析 (HD) 末期病 (ESRD) 患者中酸调节的生物标志物.
- 完整的副甲状腺激素 (iPTH) 和同氨酸 (Hcy) 也与慢性病 (CKD) 相关的矿物骨病 (MBD) 有关.
- 了解这些生物标志物与GFR,肌素,和的相互作用,对于管理ESRD患者至关重要.
研究的目的:
- 评估血小板过率 (GFR),血清肌素,和水平与HD患者的FGF-23,iPTH和Hcy之间的相关性.
- 为了确定ESRD的HD患者潜在的新预后和治疗目标.
- 探索这些生物标志物在预测CKD进展中的实用性.
主要方法:
- 在103名患有ESRD的HD患者中,对血清FGF-23,Hcy和iPTH度的回顾性分析.
- 对GFR,肌素,和水平与研究的生物标志物之间的相关性分析.
- 用于数据收集的ELISA方法;使用彩色多普勒心电图和心电图进行心脏评估.
主要成果:
- FGF-23水平与血清 (r=0.78,p=0.01),IPTH (r=0.61,p=0.01) 和肌素 (r=0.78,p=0.01) 有正相关性,与GFR (r=-0.64,p=0.01) 有负相关性.
- 在FGF-23和Hcy (r=0.65,p=0.01) 之间观察到正线性相关性.
- 在FGF-23和水平之间没有发现显著的相关性 (r=-0.12,p>0.05).
结论:
- 没有单一的生物标志物可以完全预测CKD的进展或指导随访.
- 结合FGF-23,iPTH和Hcy以及其他生化参数的评估,可以作为HD患者的早期指标.
- 这些相关的生物标志物变化可以为患HD的ESRD患者的预后策略和早期治疗管理提供信息.
相关概念视频
Serum Studies: Renal Function Tests
50
Renal function tests are crucial for assessing kidney health, monitoring disease progression, and evaluating the kidneys' efficiency in waste elimination, fluid balance, and electrolyte regulation. These tests offer critical insights into kidney function, even though routine measurements may appear normal until there is a significant decline in the glomerular filtration rate or GFR. Typically, signs of kidney impairment only become evident when the GFR falls to about 50% of its normal level.
50
Hemodialysis III: Nursing Management
196
The nursing management of a patient undergoing hemodialysis includes several critical steps, starting with a thorough assessment before the procedure.Before the Hemodialysis ProcedureFirst, record the patient's vital signs—blood pressure, heart rate, respiratory rate, and temperature—to establish a baseline. This baseline is essential for detecting conditions such as hypotension that could impact the patient's response to dialysis. Document the patient's pre-dialysis weight, as this...
196
Factors Affecting Renal Clearance: Renal Impairment
165
Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
165
Chronic Kidney Disease III: Interprofessional Care
82
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
82
Role of Hematopoietic Growth Factors
1.7K
Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
Thrombopoietin (TPO), mainly released by the liver,...
1.7K
Hemodialysis I: Introduction
310
Hemodialysis (HD) is a medical treatment that artificially removes waste products, excess fluids, and toxins from the blood when the kidneys are no longer able to perform these functions effectively. In this process, blood is filtered through a semipermeable membrane, allowing for the selective removal of waste while preserving necessary components like blood cells and proteins. Hemodialysis is typically performed in patients with end-stage renal disease (ESRD) or severe kidney...
310


